These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18834415)

  • 1. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.
    Retsky MW; Demicheli R; Hrushesky WJ; Baum M; Gukas ID
    APMIS; 2008; 116(7-8):730-41. PubMed ID: 18834415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth?
    Retsky M; Demicheli R; Hrushesky W; Baum M; Gukas I
    Cancers (Basel); 2010 Mar; 2(2):305-37. PubMed ID: 24281072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer.
    Demicheli R; Desmedt C; Retsky M; Sotiriou C; Piccart M; Biganzoli E
    Breast; 2020 Aug; 52():64-70. PubMed ID: 32428688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
    Demicheli R; Retsky MW; Hrushesky WJ; Baum M
    Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does utilization of screening mammography explain racial and ethnic differences in breast cancer?
    Smith-Bindman R; Miglioretti DL; Lurie N; Abraham L; Barbash RB; Strzelczyk J; Dignan M; Barlow WE; Beasley CM; Kerlikowske K
    Ann Intern Med; 2006 Apr; 144(8):541-53. PubMed ID: 16618951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor dormancy and frailty models: A novel approach.
    Rancoita PM; Valberg M; Demicheli R; Biganzoli E; Di Serio C
    Biometrics; 2017 Mar; 73(1):260-270. PubMed ID: 27398936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
    Demicheli R; Miceli R; Moliterni A; Zambetti M; Hrushesky WJ; Retsky MW; Valagussa P; Bonadonna G
    Ann Oncol; 2005 Sep; 16(9):1449-57. PubMed ID: 15956037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy.
    Retsky M; Demicheli R; Hrushesky W
    Breast Cancer Res Treat; 2001 Feb; 65(3):217-24. PubMed ID: 11336243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.
    Retsky M
    Int J Environ Res Public Health; 2009 Jan; 6(1):329-48. PubMed ID: 19440287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can be learnt about disease progression in breast cancer dormancy from relapse data?
    Willis L; Graham TA; Alarcón T; Alison MR; Tomlinson IP; Page KM
    PLoS One; 2013; 8(5):e62320. PubMed ID: 23671591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Does use of screening mammography explain racial and ethnic differences in death from breast cancer?
    Ann Intern Med; 2006 Apr; 144(8):I18. PubMed ID: 16618948
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer dormancy can be maintained by small numbers of micrometastases.
    Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
    Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence dynamics does not depend on the recurrence site.
    Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
    Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
    Sail K; Franzini L; Lairson D; Du X
    Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer.
    Kim RS; Avivar-Valderas A; Estrada Y; Bragado P; Sosa MS; Aguirre-Ghiso JA; Segall JE
    PLoS One; 2012; 7(4):e35569. PubMed ID: 22530051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.
    Joensuu K; Heikkilä P; Andersson LC
    Cancer Lett; 2008 Jun; 265(1):76-83. PubMed ID: 18355956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
    Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
    Breast Cancer Res Treat; 1996; 41(2):177-85. PubMed ID: 8944336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor dormancy at bedside: A late awakening.
    Demicheli R; Desmedt C; Piccart M; Biganzoli E
    Breast; 2019 Jun; 45():61-63. PubMed ID: 30878882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.